Your browser doesn't support javascript.
loading
A PML/Slit Axis Controls Physiological Cell Migration and Cancer Invasion in the CNS.
Amodeo, Valeria; A, Deli; Betts, Joanne; Bartesaghi, Stefano; Zhang, Ying; Richard-Londt, Angela; Ellis, Matthew; Roshani, Rozita; Vouri, Mikaella; Galavotti, Sara; Oberndorfer, Sarah; Leite, Ana Paula; Mackay, Alan; Lampada, Aikaterini; Stratford, Eva Wessel; Li, Ningning; Dinsdale, David; Grimwade, David; Jones, Chris; Nicotera, Pierluigi; Michod, David; Brandner, Sebastian; Salomoni, Paolo.
Afiliação
  • Amodeo V; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • A D; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • Betts J; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • Bartesaghi S; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • Zhang Y; UCL Institute of Neurology, London, WC1N 3BG, UK.
  • Richard-Londt A; UCL Institute of Neurology, London, WC1N 3BG, UK.
  • Ellis M; UCL Institute of Neurology, London, WC1N 3BG, UK.
  • Roshani R; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • Vouri M; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • Galavotti S; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • Oberndorfer S; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • Leite AP; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • Mackay A; Institute of Cancer Research, Sutton, London SM2 5NG, UK.
  • Lampada A; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK.
  • Stratford EW; The Norwegian Radium Hospital, Oslo 0379, Norway.
  • Li N; UCL Institute of Neurology, London, WC1N 3BG, UK.
  • Dinsdale D; MRC Toxicology Unit, Leicester LE1 7HB, UK.
  • Grimwade D; Guy's Hospital, King's College London, London SE1 9RT, UK.
  • Jones C; Institute of Cancer Research, Sutton, London SM2 5NG, UK.
  • Nicotera P; German Centre for Neurodegenerative Diseases (DZNE), Bonn 53127, Germany.
  • Michod D; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK; UCL Institute of Child Health, London WC1N 1EH, UK.
  • Brandner S; UCL Institute of Neurology, London, WC1N 3BG, UK.
  • Salomoni P; UCL Cancer Institute, London, WC1E 6DD, UK; Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, London, WC1E 6DD, UK. Electronic address: p.salomoni@ucl.ac.uk.
Cell Rep ; 20(2): 411-426, 2017 07 11.
Article em En | MEDLINE | ID: mdl-28700942

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / Proteína da Leucemia Promielocítica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / Proteína da Leucemia Promielocítica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido